2 December, 2011

RayPilot® exhibited by Radius at the AIRO congress in Italy

Micropos Italian distributor, Radius, exhibited the RayPilot® system for increased precision in radiotherapy of prostate cancer at the AIRO Congress in Genova.

The AIRO Congress is the annual meeting of the Italian radiotherapy society and it is the most important meeting of the year in which most of the radiotherapists meet and discuss about several radiotherapy topics.

- This year, in Genova, Radius registered a great interest in the new RayPilot® system and we had serious discussions with several clinics during the congress, we have booked follow-up demo visits, says Pierfrancesco Silli, Radiotherapy Product Specialist at RADIUS S.r.l.

Radius is a well reputable and experienced dealer of several products in radiotherapy and nuclear medicine the company represent among others Varian Particle Therapy and Advanced Cyclotron Systems.

- This is my third AIRO congress and it is clear that both the RayPilot® system and the need for detecting real time tumor motion is getting more and more established says QA/RA Manager, Hanna Syrén at Micropos who participated in the Radius booth.

Radius_booth_AIRO_2011_RayPilot Hanna_Airo_2011_RayPilot

Images: Radius booth with the RayPilot® system to the right and the right picture shows Hanna Syren from Micropos

For additional information, please contact:

Tomas Gustafsson, CEO, Micropos Medical AB (publ), +46-31-772 80 99, tomas(a)micropos.se

About Micropos Medical AB (publ):

Micropos Medical AB (publ) (www.micropos.se) is a Swedish medical device start-up that was founded in 2003 as a result of four physicians’ long clinical experience in the therapeutic radiation oncology field (cancer treatment). The company has developed the RayPilot® system for increased precision in radiotherapy of prostate cancer. The RayPilot® system is an electromagnetic positioning system that initially enables real time position of the prostate for a fast and objective set-up and for continuous positioning during the treatment. A precise and safe localization of the tumor can dramatically improve the outcome of the treatment, particularly for hypofractionated protocols. The RayPilot® system consists mainly of three parts; a transmitter that is placed in the ROI, a receiving system that is placed directly on any existing treatment coach and software that continuously shows where the tumor is and where to beam. The transmitter is removed after the final treatment in order to enable MRI follow-up.

Now you can follow the company on Facebook, http://www.facebook.com/MicroposMedical